Inicio › Enfermedad de obstrucción pulmonar crónica › Illinois
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Illinois
19 estudios sobre Enfermedad de obstrucción pulmonar crónica buscan participantes en Illinois.
Ciudades en Illinois
Texto oficial del estudio (inglés)
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Axis Clinical Trials - Westchester, Westchester
ReclutandoFase 2
Edades de 40 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- University of Illinois-Chicago - College of Medicine- Site Number : 8400055, Chicago
- Avicenna Clinical Research- Site Number : 8400126, Chicago Ridge
- NorthShore Medical Group - Evanston ( Endeavor Health)- Site Number : 8400073, Evanston
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Northwestern University, Chicago
- University of Chicago Medical Center, Chicago
- OSF Saint Francis Medical Center, Peoria
Reclutando
Edades de 40 a 80 · Todos los sexos · Actualizado el 17 sept 2026 · NCT06035120Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Christie Clinic in Champaign on University- Site Number : 8400023, Champaign
- Sneeze Wheeze & Itch Associates- Site Number : 8400020, Normal
- Peoria Pulmonary Associates Ltd- Site Number : 8400095, Peoria
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07190222Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Evanston
- Research Site, Springfield
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Palos Hills
- Research Site, Winfield
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06883305COPD Exacerbation Follow Up
- Advocate Lutheran General Hospital, Park Ridge
ReclutandoEstudio observacional
Edades de 40 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07118306A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Chicago
- Research Site, Winfield
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 26 ago 2026 · NCT06283966STRIVE Post-Market Registry Study
- Northwestern University, Division of Pulmonary and Critical Care Medicine, Chicago
- University of Chicago, Chicago
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT04302272Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
- Jesse Brown VA Medical Center, Chicago
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT06390345SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Illinois Chicago, Chicago
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 30 a 55 · Todos los sexos · Actualizado el 3 jun 2026 · NCT05033990A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
- Northwestern University, Chicago
Reclutando
Edades de 22 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT07119229Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Chicago, Chicago
- OSF St Francis Medical Center, Peoria
Reclutando
Edades de 40 a 84 · Todos los sexos · Actualizado el 24 abr 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Chicago
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 9 abr 2026 · NCT06961214PiMZ Longitudinal Cohort (PiMZ Logic)
- University of Chicago, Chicago
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 ene 2026 · NCT06505603COPD Resources, Education, and Activity Designed for You Study
- Rush University Medical Center, Chicago
Reclutando
Edades de 40 en adelante · Todos los sexos · Actualizado el 22 sept 2025 · NCT07125053Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- University of Chicago, Chicago
- Walgreens, Deerfield
- Springfield Clinic, LLP, Springfield
ReclutandoEstudio observacional
Edades de 50 en adelante · Todos los sexos · Actualizado el 5 ago 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Chicago, Chicago
Reclutando
Edades de 30 en adelante · Todos los sexos · Actualizado el 6 feb 2025 · NCT05204888De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.